Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Artist's rendition of the tell-tale "cobble-stone" colonies formed by hematopoietic stem cells (HSCs) in culture. The radial design suggests the various blood lineages spun from the central pluripotent stem cells. Five solicited commentaries and reviews in this issue of Nature Immunology are devoted to HSCs, including the controversies, progress and potential of these amazing (and vital) cells. Our Focus on HSCs website (http://immunol.nature.com) is free to registrants, will be updated regularly and contains additional features of interest to those curious about HSCs.
The potential of hematopoietic stem cells to generate tissue-specific lineages varies with the criteria used to isolate such cells. New discoveries continue to refine our definition of what a hematopoietic stem cell is and what it can do.
Multiple sources of HSCs exist. Here, Verfaillie discusses the long-term engraftment capabilities of each source and the search for ex vivo expansion conditions to allow bulk culture for therapeutic HSC transplantation.
Transfer of genes into HSCs could be used to treat a variety of diseases from AIDS to cancer. Here Bordignon and Roncarolo discuss the logistics and progress of HSC gene transfer technology for the treatment of different diseases.
Patients with severe asthma accumulate inflammatory cells in their airway walls. Studies with MMP2-deficient mice now show that an inability of these cells to egress from the lung can be fatal.
What does Coxsackie virus have to do with diabetes? Evidence is emerging that insulin-producing β cells are highly susceptible to acute infection by Coxsackie virus if their production of interferon is inhibited, resulting in diabetes.
The current paradigm is that reactive oxygen species produced by leukocytes directly kill bacteria. Data in a recent Nature article belie that simplicity.
Lack of proper tools hampers early diagnosis and treatment of antigen-specific autoimmune diseases. A new strategy that makes use of peptide-MHC reagents could control recent-onset diabetes in mice.
The hematopoietic stem cells that reside in our bone marrow might aptly be described as our source of vitality. This focus contains an analysis of progress and news in hematopoietic stem cell research.